Eurofins Scientific SE (the "Company") (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 4.

Eurofins agrees to sell its electrical testing unit to UL Solutions for $677M, focusing on core business and investments. Deal set to close by end of 2026.

Eurofins Scientific shares jumped after the laboratory testing group agreed to sell its electrical and electronics testing ...

UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced it has entered into a definitive agreement to acquire the electrical and electronics (E&E) business (inclusive ...

The Eurofins (Paris:ERF) network of companies delivered steady growth despite significant temporary headwinds: ...

Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces the signing of an agreement to divest its Electrical & Electronic Testing business ("MET Labs") to UL Solutions Inc ...

UL Solutions Inc. trades at a premium of ~45x 2026 earnings, limiting near-term upside appeal. Learn more about ULS stock ...

Eurofins’ defensive lab-testing growth: 6.5% organic target, M&A upside, buybacks, and 10–12% return potential plus 2% yield.

Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...

Eurofins Lancaster Laboratories plans to break ground this spring on a $147 million expansion that will add biopharmaceutical testing labs and office space. Construction on the connected five- and six ...